Showing results (171-180 of 218) with videos related to

Sort By:
Pageof 22
Cell Death & Disease|June 17, 2026
NuMA1 controls myonuclear motility in striated skeletal muscle through AMPK activity and is impaired in Duchenne muscular dystrophyNathalie Couturier, Léa Castellano, Alireza Ghasemizadeh, et al.
Cancers|July 3, 2020
Pimasertib Versus Dacarbazine in Patients With Unresectable <i>NRAS</i>-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with CrossoverCeleste Lebbé, Caroline Dutriaux, Thierry Lesimple, et al.
JAMA Dermatology|November 15, 2013
Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy SocietyAndreas Blum, Rainer Hofmann-Wellenhof, Ashfaq A Marghoob, et al.
Dermatology (Basel, Switzerland)|March 31, 2021
The Usefulness of Dermoscopy for the Recognition of Malignant Collision TumorsPedro Zaballos, Marcial Álvarez Salafranca, Carolina Medina, et al.
The Lancet. Oncology|May 19, 2015
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trialNicole Basset-Seguin, Axel Hauschild, Jean-Jacques Grob, et al.
Dermatology (Basel, Switzerland)|October 6, 2024
Validation of a Dermatoscopy-Based Algorithm for the Diagnosis of Acral MelanomaChristoph Müller, Harald Kittler, Philipp Tschandl, et al.
The New England Journal of Medicine|September 30, 2014
Combined vemurafenib and cobimetinib in BRAF-mutated melanomaJames Larkin, Paolo A Ascierto, Brigitte Dréno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation-Positive Advanced Melanoma: Extended Follow-up of the coBRIM StudyPaolo A Ascierto, Brigitte Dréno, James Larkin, et al.
British Journal of Cancer|February 14, 2018
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF<sup>V600</sup> mutation-positive melanomaBrigitte Dréno, Paolo A Ascierto, Victoria Atkinson, et al.
European Journal of Dermatology : EJD|January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Karen Bartley, Thomas Karagiannis, et al.
Pageof 22